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Does the small risk of fatal heart attack potentially posed by methadone justify routine 
electrocardiogram screening of patients, or will this cause more deaths by limiting an 
effective treatment for opiate addiction? A US clinic tried it and found three at-risk 
patients in three years.
Summary The QTc interval is an indicator of heart function derived from 
electrocardiogram measures. It refers to the delay between two phases of the electrical 
activity of the heart which drives it in pumping blood round the body. Extended intervals 
may lead to torsades de pointes, a potentially life threatening heart attack. Several 
studies have reported that methadone may contribute to the elongation of this interval, 
heightening the risk. The risk threshold has been variously set at 450ms (0.45 seconds) 
for men and 470ms for women or 450ms for both, though it is generally accepted that 
intervals greater than 500ms constitute a significant risk of abnormal heart function.
Given the risk, an expert US panel recommended electrocardiogram screening of all 
methadone patients when they start treatment and then a month and a year later, with 
extra tests as indicated.
A medical clinic for former US military personnel instigated such screening at the clinic 
itself to identify high risk patients. Alongside it offered brief on-site counselling for 
patients about the risks of cardiac arrhythmias associated with methadone and how to 
spot the symptoms of any impending problems. Electrocardiogram results were reviewed 
by the clinic's psychiatrist, who provided feedback for each patient and arranged for 
appropriate referrals as needed. Patients with automated readings between 450ms and 
500ms received more education and further electrocardiogram monitoring. If the interval 
reading exceeded 500ms, methadone dose was reduced and the patient was referred to a 
cardiology clinic.
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The featured article reports on the feasibility and effectiveness of these procedures 
instigated in 2007 based on the records of 55 patients treated between 2002 and 2009 
who were among the clinic's established caseload and had been retained in methadone 
treatment for at least six months and not dropped out. These patients averaged 90mg 
methadone daily.
Main findings
Urine drug screens revealed that illicit opiate and cocaine use fell during treatment, until 
just 4–5% of the latest tests were positive for each drug. All but 5% of patients 
underwent electrocardiogram screening as intended at admission and annually. At 
baseline the QTc interval averaged 417ms but increased to 442ms at the latest test, a 
statistically significant prolongation. Two thirds of the patients registered a significant 
prolongation but remained below 450ms. Another 27% ended up between 450ms and 
500ms while just 6% experienced a statistically significant QTc prolongation which ended 
by exceeding 500ms. No patient was required as a result to discontinue methadone.
Statistical tests were used to determine whether QTc prolongation was significantly 
related to methadone dose, duration in treatment, whether the patient smoked, 
concomitant use of antidepressants and antipsychotics, or cocaine use either at baseline 
or recently. Of these, only recent cocaine use was significantly related to QTc 
prolongation, both when each variable was tested one by one and when all were taken in 
to account at the same time.
The authors' conclusions
This study confirms that methadone is a safe and effective treatment for opiate 
dependence. Although other factors such as continued illicit drug use, hepatitis C, HIV 
and smoking are much more likely to lead to premature death in methadone patients 
than cardiac arrhythmias, QTc prolongation in addition to other chronic medical 
conditions may increase the risk. An electrocardiogram is an objective tool to identify 
patients at risk for cardiac arrhythmias. Although such screening itself is not expensive, 
referral to specialty care could be, but in practice providing on-site electrocardiogram 
screening with a focus on patient education and limiting referral to cardiology specialty 
care led over a three-year period to just three of 55 patients being referred.
Two thirds of retained patients in the clinic had QTc intervals within the normal range and 
only three of 55 exhibited significantly increased risk for torsades de pointes with a QTc 
of over 500ms. Interventions initiated by the addictions clinic included methadone dose 
reduction, elimination or reduction of other QTc-prolonging medications, education about 
the possible contributions of caffeine and nicotine to QTc prolongation, and detailed 
information about the signs and symptoms of arrhythmias.
The key finding in this study was that recent but not baseline use of cocaine among 
methadone patients – meaning that even when established in treatment these patients 
had continued with its use – was associated with QTc prolongation. 
 Whether the so far largely theoretical and circumstantial risk of death from 
torsades de pointes due to methadone's effects justifies routine and repeated 
electrocardiogram screening of all patients is a matter of some contention. The expert 
panel convened by the US government whose initial recommendations prompted the 
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featured study later changed its mind, due largely to concern that this might on balance 
cause more deaths by limiting an effective treatment for opiate addiction. It could mean 
delays as patients await electrocardiogram testing and results, divert resources from 
methadone treatment, lead some patients to reject or drop out of methadone treatment, 
or to sub-optimal doses, all of which could lead to preventable deaths. Faced with these 
risks the panel opted for screening high risk patients only. However, this could mean still 
having to screen most patients, as a UK study demonstrated.
In line with the featured study's findings, the latest report of the US expert panel noted 
that cocaine use seems to aggravate any impact of methadone on the QT interval. 
Laboratory studies have shown that in its own right cocaine has a marked impact on the 
QT interval. Such findings justify including use of the drug among the variables indicating 
high risk among methadone patients, one of the reasons why in parts of Britain so many 
would qualify for this designation.
High methadone doses are thought to heighten the cardiac risk but also protect against potentially fatal illicit 
opiate use. In this respect it would have been useful if the featured report had been able to record the 
consequences of the cautionary dose reductions it implemented among the sampled patients, especially 
whether urine screens indicated increased illicit drug use after methadone was reduced. Also of interest is 
whether these or other initiatives implemented as part of the described programme led any patients to refuse or 
drop out of treatment (in which case they would not have been among the sample reported on), or to be 
offered or insist on a lower than optimal dose.
See this Findings analysis of the US panel's latest report for more on the risk of death due to methadone-
provoked QT prolongation, on whether universal electrocardiogram screening is advisable given the size of this 
risk and the possible unintended consequences of requiring such screening, and on UK guidance.
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